Tuccatin 150
In stock
Description
Tucatinib 150 mg is an oral tyrosine kinase inhibitor (TKI) used to treat advanced or metastatic (HER2)-positive breast cancer and (RAS) wild-type (HER2)-positive colorectal cancer. It works by selectively blocking the (HER2) protein to slow the growth and spread of cancer cells.
Specifications
| Strength | 150 mg |
|---|---|
| Dosage Form | Oval-shaped, yellow, film-coated tablet |
| Pack Size | 60 Tablets |
| Treatment | HER2-positive metastatic breast cancer |
| Main Ingredients | Tucatinib |
| Drug Class | Kinase Inhibitor (HER2 Inhibitor) |
